Fig. 1
From: Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants
Swimmer’s plot detailing patient follow-up from the time of MEK inhibitor initiation.
Fig. 1 | Leukemia
From: Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants
Swimmer’s plot detailing patient follow-up from the time of MEK inhibitor initiation.
